| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.086 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |